Gritstone bio (GRTS) News Today → Do you know the 3 golden rules for dividend investing? (From DTI) (Ad) Free GRTS Stock Alerts $0.75 -0.03 (-3.59%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 8 at 4:57 PM | globenewswire.comStockholder Alert: Robbins LLP Informs Investors of the Class Action Lawsuit Filed Against Gritstone Bio, Inc.June 7 at 10:06 PM | prnewswire.comPomerantz announces the filing of a class action lawsuit Gritstone bio, Inc. and Certain Officers - GRTSJune 4, 2024 | globenewswire.comGritstone bio to Participate in Upcoming Investor and Scientific ConferencesMay 24, 2024 | marketbeat.comB. Riley Reaffirms "Buy" Rating for Gritstone bio (NASDAQ:GRTS)B. Riley reiterated a "buy" rating and set a $3.00 target price (down previously from $6.00) on shares of Gritstone bio in a research report on Friday.May 21, 2024 | insidertrades.comGritstone bio, Inc. (NASDAQ:GRTS) CEO Sells $18,197.25 in StockMay 20, 2024 | insidertrades.comGritstone bio, Inc. (NASDAQ:GRTS) COO Sells $10,311.75 in StockMay 18, 2024 | marketbeat.comInsider Selling: Gritstone bio, Inc. (NASDAQ:GRTS) COO Sells 13,749 Shares of StockGritstone bio, Inc. (NASDAQ:GRTS - Get Free Report) COO Erin Jones sold 13,749 shares of the stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $0.75, for a total transaction of $10,311.75. Following the completion of the transaction, the chief operating officer now directly owns 359,293 shares of the company's stock, valued at $269,469.75. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.May 16, 2024 | marketbeat.comGritstone bio, Inc. (NASDAQ:GRTS) Short Interest UpdateGritstone bio, Inc. (NASDAQ:GRTS - Get Free Report) was the target of a significant growth in short interest in April. As of April 30th, there was short interest totalling 15,110,000 shares, a growth of 18.0% from the April 15th total of 12,800,000 shares. Based on an average daily volume of 2,860,000 shares, the short-interest ratio is currently 5.3 days. Approximately 15.4% of the company's stock are sold short.May 15, 2024 | marketbeat.comHC Wainwright Weighs in on Gritstone bio, Inc.'s Q2 2024 Earnings (NASDAQ:GRTS)Gritstone bio, Inc. (NASDAQ:GRTS - Free Report) - Research analysts at HC Wainwright increased their Q2 2024 earnings per share (EPS) estimates for Gritstone bio in a report issued on Monday, May 13th. HC Wainwright analyst S. Lee now anticipates that the company will post earnings of ($0.28) perMay 13, 2024 | markets.businessinsider.comBeyond The Numbers: 4 Analysts Discuss Gritstone Bio StockMay 13, 2024 | marketbeat.comHC Wainwright Cuts Gritstone bio (NASDAQ:GRTS) Price Target to $4.00HC Wainwright cut their price target on Gritstone bio from $7.00 to $4.00 and set a "buy" rating on the stock in a report on Monday.May 11, 2024 | marketbeat.comGritstone bio (NASDAQ:GRTS) Releases Quarterly Earnings Results, Misses Estimates By $0.04 EPSGritstone bio (NASDAQ:GRTS - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.34) earnings per share for the quarter, missing analysts' consensus estimates of ($0.30) by ($0.04). Gritstone bio had a negative net margin of 926.13% and a negative return on equity of 184.66%. The business had revenue of $1.74 million for the quarter, compared to the consensus estimate of $5.90 million. During the same period last year, the firm posted ($0.30) EPS.May 11, 2024 | finance.yahoo.comGritstone bio First Quarter 2024 Earnings: Misses ExpectationsMay 9, 2024 | msn.comGritstone bio GAAP EPS of -$0.34 misses by $0.02, revenue of $1.74M misses by $1.11MMay 9, 2024 | finance.yahoo.comGritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesMay 3, 2024 | marketbeat.comGritstone bio (GRTS) Set to Announce Earnings on ThursdayGritstone bio (NASDAQ:GRTS) will be releasing earnings after the market closes on Thursday, May 9, Zacks reports.May 2, 2024 | globenewswire.comGritstone bio to Report First Quarter 2024 Financial Results and Provide Corporate Updates on May 9, 2024April 29, 2024 | globenewswire.comGritstone bio Announces Appointment of Stephen Webster to its Board of DirectorsApril 20, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTSApril 17, 2024 | marketbeat.comQ2 2024 Earnings Estimate for Gritstone bio, Inc. Issued By B. Riley (NASDAQ:GRTS)Gritstone bio, Inc. (NASDAQ:GRTS - Free Report) - Equities researchers at B. Riley issued their Q2 2024 earnings estimates for Gritstone bio in a research report issued to clients and investors on Tuesday, April 16th. B. Riley analyst M. Mamtani expects that the company will post earnings per shaApril 15, 2024 | finance.yahoo.comNature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)April 15, 2024 | globenewswire.comNature Medicine Publishes Interim Results from Gritstone bio's Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)April 12, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTSApril 10, 2024 | stockhouse.comGritstone bio Presents Improvements to EDGE(TM) Platform at AACR 2024April 8, 2024 | markets.businessinsider.comBuy Rating Affirmed: Gritstone Oncology’s Promising Growth and Technological AdvancementsApril 8, 2024 | finance.yahoo.comGritstone bio Presents Improvements to EDGE™ Platform at AACR 2024April 4, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTSApril 3, 2024 | benzinga.comGritstone Bio Stock (NASDAQ:GRTS), Quotes and News SummaryApril 2, 2024 | markets.businessinsider.comNasdaq Down Over 1%; VivoPower International Shares Spike HigherApril 2, 2024 | msn.comWhat's Going On With Small Cap Cancer Vaccine Focused Gritstone Bio Stock On Tuesday?April 2, 2024 | marketbeat.comGritstone bio (NASDAQ:GRTS) PT Raised to $5.00 at JMP SecuritiesJMP Securities lifted their price target on Gritstone bio from $4.00 to $5.00 and gave the company a "market outperform" rating in a research note on Tuesday.April 2, 2024 | investorplace.comWhy Are Health Insurance Stocks HUM, UNH, CI Down Today?April 2, 2024 | marketwatch.comGritstone Bio Shares Drop 33% After Public Offering PricesApril 2, 2024 | investorplace.comWhy Is Gritstone Bio (GRTS) Stock Down 44% Today?April 2, 2024 | marketbeat.comGritstone bio, Inc. (NASDAQ:GRTS) Short Interest Up 7.3% in MarchGritstone bio, Inc. (NASDAQ:GRTS - Get Free Report) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 8,820,000 shares, a growth of 7.3% from the February 29th total of 8,220,000 shares. Approximately 9.9% of the company's stock are short sold. Based on an average trading volume of 2,050,000 shares, the short-interest ratio is currently 4.3 days.April 1, 2024 | globenewswire.comGritstone bio Announces Pricing of $32.5 Million Underwritten Public OfferingApril 1, 2024 | msn.comGritstone stock plunges 35% on mixed Phase 2 data, public offeringApril 1, 2024 | globenewswire.comGritstone bio Announces Proposed Public OfferingApril 1, 2024 | globenewswire.comGritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)March 28, 2024 | seekingalpha.comGRTS Gritstone bio, Inc.March 19, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gritstone bio, Inc. - GRTSMarch 18, 2024 | msn.comDo Options Traders Know Something About Gritstone bio (GRTS) Stock We Don't?March 11, 2024 | marketbeat.comResearch Analysts Set Expectations for Gritstone bio, Inc.'s Q1 2024 Earnings (NASDAQ:GRTS)Gritstone bio, Inc. (NASDAQ:GRTS - Free Report) - Investment analysts at HC Wainwright upped their Q1 2024 earnings per share (EPS) estimates for Gritstone bio in a research note issued to investors on Wednesday, March 6th. HC Wainwright analyst S. Lee now forecasts that the company will post earMarch 8, 2024 | finance.yahoo.comGritstone bio, Inc. (NASDAQ:GRTS) Just Reported And Analysts Have Been Cutting Their EstimatesMarch 8, 2024 | marketbeat.comFY2028 Earnings Forecast for Gritstone bio, Inc. Issued By HC Wainwright (NASDAQ:GRTS)Gritstone bio, Inc. (NASDAQ:GRTS - Free Report) - Equities research analysts at HC Wainwright issued their FY2028 earnings per share (EPS) estimates for shares of Gritstone bio in a report issued on Wednesday, March 6th. HC Wainwright analyst S. Lee anticipates that the company will post earningsMarch 7, 2024 | finance.yahoo.comGritstone Bio Inc (GRTS) Reports Fiscal Year 2023 Financial Results and Corporate UpdatesMarch 7, 2024 | finance.yahoo.comGritstone bio Full Year 2023 Earnings: Beats ExpectationsMarch 6, 2024 | marketbeat.comHC Wainwright Reiterates Buy Rating for Gritstone bio (NASDAQ:GRTS)HC Wainwright restated a "buy" rating and set a $7.00 price target on shares of Gritstone bio in a research note on Wednesday.March 5, 2024 | globenewswire.comGritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdatesMarch 5, 2024 | finance.yahoo.comGRTS Apr 2024 0.500 put Get Gritstone bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address Executive Order To Wipe Out Your Bank Accounts (Ad)Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast. Click Here To Get Your FREE Guide Now! GRTS Media Mentions By Week GRTS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRTS News Sentiment▼0.000.76▲Average Medical News Sentiment GRTS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRTS Articles This Week▼32▲GRTS Articles Average Week Get Gritstone bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ATRA News Today SLDB News Today TNYA News Today GNFT News Today BDTX News Today PSTX News Today IPSC News Today ADAP News Today MGX News Today CADL News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRTS) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored